| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |